174 related articles for article (PubMed ID: 26082227)
1. Transient Glyco-Engineering of N. benthamiana Aiming at the Synthesis of Multi-antennary Sialylated Proteins.
Loos A; Castilho A
Methods Mol Biol; 2015; 1321():233-48. PubMed ID: 26082227
[TBL] [Abstract][Full Text] [Related]
2. Transient Expression of Mammalian Genes in N. benthamiana to Modulate N-Glycosylation.
Castilho A; Steinkellner H
Methods Mol Biol; 2016; 1385():99-113. PubMed ID: 26614284
[TBL] [Abstract][Full Text] [Related]
3. Knockout of Glycosyltransferases in Nicotiana benthamiana by Genome Editing to Improve Glycosylation of Plant-Produced Proteins.
Jansing J; Bortesi L
Methods Mol Biol; 2022; 2480():241-284. PubMed ID: 35616867
[TBL] [Abstract][Full Text] [Related]
4. Engineering of human-type O-glycosylation in Nicotiana benthamiana plants.
Strasser R
Bioengineered; 2013; 4(4):191-6. PubMed ID: 23147167
[TBL] [Abstract][Full Text] [Related]
5. Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue.
Schneider JD; Castilho A; Neumann L; Altmann F; Loos A; Kannan L; Mor TS; Steinkellner H
Biotechnol J; 2014 Apr; 9(4):501-10. PubMed ID: 24130173
[TBL] [Abstract][Full Text] [Related]
6. The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants.
Limkul J; Iizuka S; Sato Y; Misaki R; Ohashi T; Ohashi T; Fujiyama K
Plant Biotechnol J; 2016 Aug; 14(8):1682-94. PubMed ID: 26868756
[TBL] [Abstract][Full Text] [Related]
7. Promoter Choice Impacts the Efficiency of Plant Glyco-Engineering.
Kallolimath S; Gruber C; Steinkellner H; Castilho A
Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28755501
[TBL] [Abstract][Full Text] [Related]
8. Assessment of transient expression strategies to sialylate recombinant proteins in N. benthamiana.
Izadi S; Kunnummel V; Steinkellner H; Werner S; Castilho A
J Biotechnol; 2023 Mar; 365():48-53. PubMed ID: 36805356
[TBL] [Abstract][Full Text] [Related]
9. A genome-edited N. benthamiana line for industrial-scale production of recombinant glycoproteins with targeted N-glycosylation.
Kogelmann B; Melnik S; Bogner M; Kallolimath S; Stöger E; Sun L; Strasser R; D'Aoust MA; Lavoie PO; Saxena P; Gach JS; Steinkellner H
Biotechnol J; 2024 Jan; 19(1):e2300323. PubMed ID: 37804142
[TBL] [Abstract][Full Text] [Related]
10. Production of Highly Sialylated Recombinant Glycoproteins Using Ricinus communis Agglutinin-I-Resistant CHO Glycosylation Mutants.
Goh JS; Chan KF; Song Z
Methods Mol Biol; 2015; 1321():323-33. PubMed ID: 26082232
[TBL] [Abstract][Full Text] [Related]
11. Using glyco-engineering to produce therapeutic proteins.
Dicker M; Strasser R
Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280
[TBL] [Abstract][Full Text] [Related]
12. Transient Recombinant Protein Production in Glycoengineered
Sukenik SC; Karuppanan K; Li Q; Lebrilla CB; Nandi S; McDonald KA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659495
[TBL] [Abstract][Full Text] [Related]
13. Glyco-engineering of biotherapeutic proteins in plants.
Ko K; Ahn MH; Song M; Choo YK; Kim HS; Ko K; Joung H
Mol Cells; 2008 Jun; 25(4):494-503. PubMed ID: 18443408
[TBL] [Abstract][Full Text] [Related]
14. Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.
Decker EL; Wiedemann G; Reski R
Methods Mol Biol; 2015; 1321():213-24. PubMed ID: 26082225
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production.
Li J; Stoddard TJ; Demorest ZL; Lavoie PO; Luo S; Clasen BM; Cedrone F; Ray EE; Coffman AP; Daulhac A; Yabandith A; Retterath AJ; Mathis L; Voytas DF; D'Aoust MA; Zhang F
Plant Biotechnol J; 2016 Feb; 14(2):533-42. PubMed ID: 26011187
[TBL] [Abstract][Full Text] [Related]
16. Challenges in therapeutic glycoprotein production.
Sethuraman N; Stadheim TA
Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
[TBL] [Abstract][Full Text] [Related]
17. Toward stable genetic engineering of human O-glycosylation in plants.
Yang Z; Bennett EP; Jørgensen B; Drew DP; Arigi E; Mandel U; Ulvskov P; Levery SB; Clausen H; Petersen BL
Plant Physiol; 2012 Sep; 160(1):450-63. PubMed ID: 22791304
[TBL] [Abstract][Full Text] [Related]
18. Recombinant protein expression in Nicotiana.
Matoba N; Davis KR; Palmer KE
Methods Mol Biol; 2011; 701():199-219. PubMed ID: 21181532
[TBL] [Abstract][Full Text] [Related]
19. Recombinant plant-derived human IgE glycoproteomics.
Montero-Morales L; Maresch D; Castilho A; Turupcu A; Ilieva KM; Crescioli S; Karagiannis SN; Lupinek C; Oostenbrink C; Altmann F; Steinkellner H
J Proteomics; 2017 May; 161():81-87. PubMed ID: 28400175
[TBL] [Abstract][Full Text] [Related]
20. An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana.
Castilho A; Beihammer G; Pfeiffer C; Göritzer K; Montero-Morales L; Vavra U; Maresch D; Grünwald-Gruber C; Altmann F; Steinkellner H; Strasser R
Plant Biotechnol J; 2018 Oct; 16(10):1700-1709. PubMed ID: 29479800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
